A complicated multisystem flare of systemic lupus erythematosus during pregnancy

We report a case of systemic lupus erythematosus (SLE) in a young woman who became pregnant amid a severe flare. She continued to have active disease in the face of aggressive treatments complicated by several side effects of immunosuppressive drugs including recurrent sepsis and gestational diabetes. Her fetus was at risk for congenital heart block during the second and third trimesters. Despite an extremely guarded prognosis, she delivered a healthy baby girl. This case highlights the complexities of SLE management during pregnancy. We discuss the therapeutic options available in pregnancy, and highlight the importance of cross-specialty multidisciplinary care in these women.

[1]  P. Ravani,et al.  Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. , 2016, Journal of autoimmunity.

[2]  L. Poston,et al.  Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. , 2016, Kidney international.

[3]  Mimi Y. Kim,et al.  Predictors of Pregnancy Outcomes in Patients With Lupus. , 2016, Annals of internal medicine.

[4]  J. Chen,et al.  A systematic analysis of world-wide population-based data on the global burden of chronic kidney disease in 2010 , 2015, Kidney international.

[5]  P. Chowdhury,et al.  Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years’ experience , 2015, BMC Nephrology.

[6]  I. Bruce,et al.  Indications for IVIG in rheumatic diseases. , 2015, Rheumatology.

[7]  K. Hyrich,et al.  Biologic therapies and pregnancy: the story so far. , 2014, Rheumatology.

[8]  C. Nelson-Piercy,et al.  Tacrolimus is an effective treatment for lupus nephritis in pregnancy , 2014, Lupus.

[9]  J. Levy,et al.  Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids , 2013, Annals of the rheumatic diseases.

[10]  C. Nelson-Piercy,et al.  Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[11]  C. Nelson-Piercy,et al.  Pregnancy and renal outcomes in lupus nephritis: an update and guide to management , 2012, Lupus.

[12]  Mimi Y. Kim,et al.  Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus , 2012, Circulation.

[13]  F. Luan,et al.  New-Onset Diabetes Mellitus in Kidney Transplant Recipients Discharged on Steroid-Free Immunosuppression , 2011, Transplantation.

[14]  Kent R Bailey,et al.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[15]  Mimi Y. Kim,et al.  Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine , 2010, Annals of the rheumatic diseases.

[16]  A Tincani,et al.  Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. , 2010, Arthritis and rheumatism.

[17]  Mimi Y Kim,et al.  Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. , 2010, Arthritis and rheumatism.

[18]  R. Scofield,et al.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease , 2010, Lupus.

[19]  Saskia le Cessie,et al.  The effect of preconception counselling on lifestyle and other behaviour before and during pregnancy. , 2008, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[20]  R. Perricone,et al.  Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. , 2008, Rheumatology.

[21]  J. Davison,et al.  Pregnancy after transplantation. , 2000, Transplantation reviews.

[22]  A. Ledo,et al.  In utero exposure to mycophenolate mofetil: A characteristic phenotype? , 2008, American journal of medical genetics. Part A.

[23]  L. Magder,et al.  Hydroxychloroquine in lupus pregnancy. , 2006, Arthritis and rheumatism.

[24]  C. Gordon,et al.  Anti-inflammatory and immunosuppressive drugs and reproduction , 2006, Arthritis research & therapy.

[25]  J. Piette,et al.  Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. , 2005, Autoimmunity reviews.

[26]  G. Pardi,et al.  Undesired effects of steroids during pregnancy. , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[27]  R. Balshaw,et al.  New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  L. Hornberger,et al.  Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. , 2003, The Journal of pediatrics.

[29]  M. Lucas,et al.  Renal disease in pregnancy. , 2001, Obstetrics and gynecology clinics of North America.

[30]  A. Tincani,et al.  Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. , 2001, Arthritis and rheumatism.

[31]  B. Tura,et al.  Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study , 2001, Lupus.

[32]  H. Julkunen,et al.  The rate of recurrence of isolated congenital heart block: a population-based study. , 2001, Arthritis and rheumatism.

[33]  R. Friedman,et al.  Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. , 2001, Journal of the American College of Cardiology.

[34]  D. Friedman,et al.  Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. , 1998, Journal of the American College of Cardiology.

[35]  M. Petri,et al.  Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. , 1993, The Journal of rheumatology.

[36]  A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. , 1991, The New England journal of medicine.

[37]  P. Houillier,et al.  Pregnancy in lupus nephritis and related disorders. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  G. Anderson,et al.  Placental transfer of methylprednisolone following maternal intravenous administration. , 1981, American journal of obstetrics and gynecology.